What is the share price of Medico Remedies Ltd (MEDICO) today?
The share price of MEDICO as on 16th September 2026 is ₹35.33. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Medico Remedies Ltd (MEDICO) share?
The past returns of Medico Remedies Ltd (MEDICO) share are- Past 1 week: -8.23%
- Past 1 month: -21.82%
- Past 3 months: -17.27%
- Past 6 months: -10.84%
- Past 1 year: -8.84%
- Past 3 years: -49.32%
- Past 5 years: 46.07%
What are the peers or stocks similar to Medico Remedies Ltd (MEDICO)?
The peers or stocks similar to Medico Remedies Ltd (MEDICO) include:What is the market cap of Medico Remedies Ltd (MEDICO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Medico Remedies Ltd (MEDICO) is ₹293.18 Cr as of 16th September 2026.What is the 52 week high and low of Medico Remedies Ltd (MEDICO) share?
The 52-week high of Medico Remedies Ltd (MEDICO) is ₹56.88 and the 52-week low is ₹30.22.What is the PE and PB ratio of Medico Remedies Ltd (MEDICO) stock?
The P/E (price-to-earnings) ratio of Medico Remedies Ltd (MEDICO) is 22.36. The P/B (price-to-book) ratio is 3.88.Which sector does Medico Remedies Ltd (MEDICO) belong to?
Medico Remedies Ltd (MEDICO) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Medico Remedies Ltd (MEDICO) shares?
You can directly buy Medico Remedies Ltd (MEDICO) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Medico Remedies Ltd
MEDICO Share Price
NSE₹35.330.98% (-0.35)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
MEDICO Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
HighStrong financials and growth story over the years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
MEDICO Performance & Key Metrics
MEDICO Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 21.44 | 3.92 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 46.29 | 5.81 | 0.49% |
MEDICO Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
MEDICO Company Profile
Medico Remedies is engaged in the manufacturing of allopathic pharmaceutical preparations
SUNPHARMA
PE Ratio
38.35
38.35
1Y Return
15.08%
15.08%
Buy Reco %
93.55
93.55
TORNTPHARM
PE Ratio
85.27
85.27
1Y Return
36.60%
36.60%
Buy Reco %
81.48
81.48
ZYDUSLIFE
PE Ratio
21.75
21.75
1Y Return
6.59%
6.59%
Buy Reco %
57.69
57.69
CIPLA
PE Ratio
28.13
28.13
1Y Return
12.89%
12.89%
Buy Reco %
62.86
62.86
LAURUSLABS
PE Ratio
117.14
117.14
1Y Return
112.52%
112.52%
Buy Reco %
58.33
58.33
MEDICO Forecast
MEDICO Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
MEDICO
MEDICO
Income
Balance Sheet
Cash Flow
Quarterly Normal View
MEDICO Income Statement
MEDICO Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 41.91 | 31.09 | 40.03 | 40.91 | 41.60 | 38.91 | 54.36 | 59.36 | 59.68 | 70.57 | ||||||||||
Operating & Other expenses | 36.68 | 27.99 | 36.94 | 36.38 | 34.64 | 35.43 | 49.92 | 54.35 | 49.66 | 66.10 | ||||||||||
EBITDA | 5.23 | 3.10 | 3.09 | 4.53 | 6.96 | 3.48 | 4.44 | 5.01 | 10.02 | 4.47 | ||||||||||
| Depreciation/Amortization | 0.74 | 0.75 | 0.75 | 0.76 | 0.77 | 0.77 | 0.73 | 0.79 | 0.80 | 0.72 | ||||||||||
| PBIT | 4.49 | 2.35 | 2.34 | 3.77 | 6.19 | 2.71 | 3.71 | 4.22 | 9.22 | 3.75 | ||||||||||
| Interest & Other Items | 0.25 | 0.18 | 0.21 | 0.28 | 0.49 | 0.28 | 0.24 | 0.39 | 0.90 | 0.41 | ||||||||||
| PBT | 4.24 | 2.17 | 2.13 | 3.49 | 5.70 | 2.43 | 3.47 | 3.83 | 8.32 | 3.34 | ||||||||||
| Taxes & Other Items | 1.14 | 0.59 | 0.58 | 0.88 | 1.36 | 0.62 | 0.90 | 0.96 | 2.47 | 0.82 | ||||||||||
| Net Income | 3.10 | 1.58 | 1.55 | 2.61 | 4.34 | 1.81 | 2.57 | 2.87 | 5.85 | 2.52 | ||||||||||
| EPS | 0.37 | 0.19 | 0.19 | 0.32 | 0.52 | 0.22 | 0.31 | 0.35 | 0.71 | 0.30 |
MEDICO Company Updates
MEDICO Stock Peers
MEDICO Past Performance & Peer Comparison
MEDICO Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Medico Remedies Ltd | 22.58 | 3.92 | — |
| Sun Pharmaceutical Industries Ltd | 38.35 | 5.25 | 0.87% |
| Torrent Pharmaceuticals Ltd | 85.27 | 10.49 | 0.70% |
| Zydus Lifesciences Ltd | 21.75 | 3.71 | 0.09% |
MEDICO Stock Price Comparison
Compare MEDICO with any stock or ETFCompare MEDICO with any stock or ETF
MEDICO
MEDICO Holdings
MEDICO Shareholdings
MEDICO Promoter Holdings Trend
MEDICO Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
MEDICO Institutional Holdings Trend
MEDICO Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
MEDICO Shareholding Pattern
MEDICO Shareholding Pattern
MEDICO Shareholding History
MEDICO Shareholding History
Foreign Institutions
smallcases containing MEDICO stock
smallcases containing MEDICO stock
Looks like this stock is not in any smallcase yet.
MEDICO Events
MEDICO Events
MEDICO Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
MEDICO has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
MEDICO Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
MEDICO has not given any dividends in last 5 years
MEDICO Dividends
MEDICO Dividends
Hmm, looks like data is unavailable here. Please come back after some timeMEDICO Stock News & Opinions
MEDICO Stock News & Opinions
Articles & Videos
Corporate
Corporate
Medico Remedies closes its register of members for the 32nd Annual General MeetingMedico Remedies Limited informed the BSE Limited and National Stock Exchange of India Limited that the register of members and share transfer book will be closed from Wednesday, September 16, 2026, to Tuesday, September 22, 2026, for the 32nd Annual General Meeting scheduled on Tuesday, September 22, 2026.
2 weeks agoCapital Market - Live
Corporate
Corporate
Medico Remedies Limited to review quarterly results at board meeting on August 13Medico Remedies Limited will hold a board meeting on Thursday, August 13, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, along with the limited review report thereon.
1 month agoCapital Market - Live
Spotlight
Spotlight
Medico Remedies Ltd. secures Rs 13.38 crore government supply order from PROMESE/CALMedico Remedies Ltd. announced it has secured a government supply order worth USD 1406450 (approximately Rs 13.38 Crores) from PROMESE/CAL, the Dominican Republic's centralized medicine and health supplies program, to supply tablets, capsules, and dry syrups. The order, awarded by an international entity, requires Medico Remedies Ltd. to complete the supply within 3 months, and does not involve any related party transactions.
1 month agoCapital Market - Live
Earnings
Earnings
Medico Remedies standalone net profit rises 35.02% in the March 2026 quarterNet profit of Medico Remedies rose 35.02% to Rs 5.86 crore in the quarter ended March 2026 as against Rs 4.34 crore during the previous quarter ended March 2025. Sales rose 37.55% to Rs 56.81 crore in the quarter ended March 2026 as against Rs 41.30 crore during the previous quarter ended March 2025. For the full year,net profit rose 30.03% to Rs 13.12 crore in the year ended March 2026 as against Rs 10.09 crore during the previous year ended March 2025. Sales rose 36.73% to Rs 206.38 crore in the year ended March 2026 as against Rs 150.94 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales56.8141.30 38 206.38150.94 37 OPM %12.6016.15 -8.269.94 - PBDT9.136.47 41 21.1616.53 28 PBT8.335.70 46 18.0713.50 34 NP5.864.34 35 13.1210.09 30 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Corporate
Medico Remedies to announce Quarterly ResultMedico Remedies will hold a meeting of the Board of Directors of the Company on 21 May 2026.
4 months agoCapital Market - Live
Earnings
Earnings
Medico Remedies standalone net profit rises 9.54% in the December 2025 quarterNet profit of Medico Remedies rose 9.54% to Rs 2.87 crore in the quarter ended December 2025 as against Rs 2.62 crore during the previous quarter ended December 2024. Sales rose 48.59% to Rs 58.68 crore in the quarter ended December 2025 as against Rs 39.49 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales58.6839.49 49 OPM %7.387.88 - PBDT4.624.26 8 PBT3.833.50 9 NP2.872.62 10 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Medico Remedies announces board meeting dateMedico Remedies will hold a meeting of the Board of Directors of the Company on 12 February 2026.Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Earnings
Medico Remedies standalone net profit rises 65.81% in the September 2025 quarterNet profit of Medico Remedies rose 65.81% to Rs 2.57 crore in the quarter ended September 2025 as against Rs 1.55 crore during the previous quarter ended September 2024. Sales rose 33.77% to Rs 52.64 crore in the quarter ended September 2025 as against Rs 39.35 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales52.6439.35 34 OPM %5.176.12 - PBDT4.202.88 46 PBT3.472.13 63 NP2.571.55 66 Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Corporate
Medico Remedies to table resultsMedico Remedies will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Corporate
Medico Remedies wins export order from PROMESE/CAL, Dominican RepublicMedico Remedies has secured government supply order for USD 1,116,517 to supply to PROMESE/CAL, Dominican Republic. PROMESE/CAL (Programa de Medicamentos Esenciales y Central de Log'stica) is the program responsible for the centralized purchase and distribution of medicines, health supplies and laboratory reagents that meets the demand of the National Public Health System in the Country of Dominican Republic. Medico Remedies has secured the order to supply tablets, capsules and dry syrups to PROMESE/CAL and will complete the supply of the full order within 3 months. Powered by Capital Market - Live
10 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 11.46%, vs industry avg of 11.79%
Over the last 5 years, market share stayed at 0.04%
Over the last 5 years, net income has grown at a yearly rate of 38.31%, vs industry avg of 10.53%